As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marlies Wijsenbeek about data from the whole follow-up period of the FIBRONEER-ILD trial of nerandomilast in progressive pulmonary fibrosis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01272-2025).

English and Japanese versions of the patient podcast to accompany the article are available from: https://publications.ersnet.org/content/erj/68/1/2501899#edit-group-supplementary-material

Cite this podcast as: ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis. Eur Respir J 2026; 68: 26E6801 [https://doi.org/10.1183/13993003.E6801-2026].

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör ERS Publications Podcasts. Innehållet i podden är skapat av ERS Publications Podcasts och inte av, eller tillsammans med, Poddtoppen.